Aberdeen Group’s Arcutis Biotherapeutics ARQT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.46M | Buy |
675,034
+87,494
| +15% | +$1.23M | 0.02% | 607 |
|
|
2025
Q1 | $9.19M | Buy |
587,540
+105,466
| +22% | +$1.65M | 0.02% | 580 |
|
|
2024
Q4 | $6.72M | Hold |
482,074
| – | – | 0.01% | 591 |
|
|
2024
Q3 | $4.48M | Buy |
482,074
+333,200
| +224% | +$3.1M | 0.01% | 664 |
|
|
2024
Q2 | $1.38M | Hold |
148,874
| – | – | ﹤0.01% | 792 |
|
|
2024
Q1 | $1.48M | Hold |
148,874
| – | – | ﹤0.01% | 801 |
|
|
2023
Q4 | $481K | Buy |
+148,874
| New | +$481K | ﹤0.01% | 886 |
|